| Literature DB >> 28836971 |
Yvon M den Hartog1, Gerjon Hannink2, Nick T van Dasselaar3, Nina M Mathijssen4, Stephan B Vehmeijer4.
Abstract
BACKGROUND: In our hospital a fast-track setting including a multimodal pain protocol is used for total hip arthroplasty (THA). Despite this multimodal pain protocol there is still a large range in reported postoperative pain between patients, which hinders mobilization and rehabilitation postoperatively. The goal of this study was to identify which patient-specific and surgical characteristics influence postoperative pain after THA in a fast-track setting.Entities:
Keywords: Fast-track; Multimodal pain protocol; Pain management; Postoperative pain; Total hip arthroplasty
Mesh:
Substances:
Year: 2017 PMID: 28836971 PMCID: PMC5571579 DOI: 10.1186/s12891-017-1725-8
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
The standardized multimodal protocol for perioperative pain medication
| Timing | Medication |
|---|---|
| 2 h before surgery | Paracetamol (acetaminophen) 1000 mg per os. |
| Celecoxib (Celebrex®) a 400 mg per os. | |
| Gabapentin 600 mg per os. | |
| Just before surgery | Dexamethasone 0.15 mg/kg iv. b |
| Esketamine 15 mg iv. | |
| 4 h after surgery | Paracetamol (acetaminophen) 1000 mg per os. |
| 8 h after surgery | Paracetamol (acetaminophen) 1000 mg per os. |
| Gabapentin 300 mg per os. | |
| Before the night | Tramadol 100 mg supp. |
| Day 1 | Paracetamol (acetaminophen) 1000 mg per os 4 times a day. |
| Celecoxib (Celebrex®) a 200 mg per os in the morning. | |
| Gabapentin 300 mg per os in the morning. | |
| After day 1 | Paracetamol (acetaminophen) 1000 mg per os 4 times a day (with a maximum of 2 weeks). |
| Celecoxib (Celebrex®) a 200 mg per os in the morning (until 2 weeks after surgery). | |
| Rescue medication | Celecoxib (Celebrex®) a 200 mg per os extra after the first night |
The standardized multimodal protocol for perioperative pain medication was determined based on literature [7–12]
aIn combination with celecoxib (Celebrex®) all patients will receive omeprazol 20 mg per os once a day as prophylaxis. When the patient was already using a proton pomp inhibitor before admittance no omeprazol was administered
bDexamethasone solution in 50cm3 saline is administered slowly to avoid adverse side effects like severe perianal pain
Fig. 1Overview of pre- and postoperative pain measurements. Postoperative pain determined with the NRS was collected at 17 standardised moments, from 1 h after surgery until the afternoon of the second day after surgery
Patient characteristics for the total group of 74 patients undergoing primary total hip arthroplasty
| Total n (%) | ||
|---|---|---|
| Age (year) | 67.1 (42.7–84.6) a | |
| BMI (kg/m2) | 27.1 (20.1–38.9) a | |
| Gender | male | 36 (48.6%) |
| ASA classification | ASA2 | 47 (63.5%) |
| Surgery time (minutes) | 79.2 (49–116) a | |
| Diabetes Mellitus | 7 (9.5%) | |
| Incision length (cm) | 9.97 (7.5–12.0) a | |
| Living situation | with cohabitants | 58 (78.4%) |
| Preoperative antidepressants use | 4 (5.4%) | |
| Preoperative pain medication use | 50 (67.6%) | |
| Preoperative pain (NRS) b | 5.26 (0–9) a | |
| DN4 | likely | 16 (21.6%) |
| APAIS anxiety | yes | 15 (23.1%) |
| APAIS information | no/little | 24 (37.5%) |
| average | 24 (37.5%) | |
| high | 16 (25.0%) | |
amean (range)
b n = 72 patients
Pain scores determined with the NRS at the standardized moments
| NRS | N | mean (range) | |
|---|---|---|---|
| Preoperative | 72 | 5.26 (0.0–9.0) | |
| Day of surgery | 1 h | 69 | 1.51 (0.0–8.0) |
| 4 h | 74 | 2.97 (0.0–9.0) | |
| Before mobilization | 69 | 2.62 (0.0–6.0) | |
| After mobilization | 65 | 2.93 (0.0–10.0) | |
| 8 h | 72 | 2.40 (0.0–8.0) | |
| Day 1 | Morning | 67 | 1.63 (0.0–5.0) |
| Before mobilization | 72 | 1.71 (0.0–7.0) | |
| After mobilization | 71 | 2.25 (0.0–9.0) | |
| Afternoon | 60 | 1.57 (0.0–6.0) | |
| Before mobilization | 54 | 1.26 (0.0–4.0) | |
| After mobilization | 54 | 1.73 (0.0–6.0) | |
| Day 2 | Morning | 39 | 2.00 (0.0–7.0) |
| Before mobilization | 41 | 1.54 (0.0–6.0) | |
| After mobilization | 41 | 1.84 (0.0–4.5) | |
| Afternoon | 14 | 1.82 (0.0–3.0) | |
| Before mobilization | 15 | 1.27 (0.0–3.0) | |
| After mobilization | 15 | 1.93 (0.0–4.0) |
Regression coefficients with 95% CIs for potential factors associated with increased postoperative pain after THA in a fast-track setting
| Univariable analyses | Multivariable analysis | ||||
|---|---|---|---|---|---|
| coefficient (95% CI) |
| coefficient (95% CI) |
| ||
| Age | 0.006 (−0.02–0.03) | 0.66 | – | – | |
| BMI | 0.03 (−0.03–0.09) | 0.28 | – | – | |
| Gender | male vs. female | −0.31 (−0.79–0.18) | 0.22 | – | – |
| ASA classification | ASA2 vs. ASA1 | 0.30 (−0.21–0.80) | 0.25 | – | – |
| Surgery time | −0.01 (−0.03–0.0005) | 0.06 | 0.0004 (−0.01–0.01) | 0.96 | |
| Diabetes Mellitus | −0.05 (−0.88–0.78) | 0.92 | – | – | |
| Incision length | 0.02 (−0.26–0.31) | 0.89 | – | – | |
| Living situation | with cohabitants vs. alone | 0.53 (−0.05–1.10) | 0.08 | 0.50 (−0.08–1.07) | 0.11 |
| Preoperative antidepressants use | yes vs. no | 0.66 (−0.39–1.71) | 0.22 | – | – |
| Preoperative pain medication use | yes vs. no | 0.68 (0.18–1.18) | 0.009 | 0.78 (0.28–1.26) | 0.005 |
| Preoperative pain | 0.10 (−0.01–0.21) | 0.08 | −0.02 (−0.13–0.09) | 0.73 | |
| DN4 | likely vs. unlikely | 0.70 (0.13–1.28) | 0.02 | 0.68 (0.15–1.20) | 0.02 |
| APAIS anxiety | yes vs. no | −0.06 (−0.67–0.54) | 0.84 | – | – |
| APAIS information | average vs. no/little | −0.02 (−0.61–0.56) | 0.93 | −0.21 (−0.74–0.31) | 0.45 |
| high vs. no/little | 0.50 (−0.16–1.15) | 0.15 | 0.45 (−0.12–1.02) | 0.15 | |
Factors that were associated with the outcome in univariable analyses (p-values <0.20) were included in a multivariable linear mixed model for repeated measures. In the multivariable analyses p-values <0.05 were considered significant